Smith & Nephew (SN) Competitors GBX 986.80 +10.80 (+1.11%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability SN vs. HLN, SGE, WHR, ANP, CLX, TPX, PNPL, LEG, ULVR, and MXCTShould you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include Haleon (HLN), The Sage Group (SGE), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), Unilever (ULVR), and MaxCyte (MXCT). Smith & Nephew vs. Haleon The Sage Group Warehouse REIT Anpario Calnex Solutions TPXimpact Pineapple Power Legendary Investments Unilever MaxCyte Smith & Nephew (LON:SN) and Haleon (LON:HLN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, community ranking, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends. Does the media favor SN or HLN? In the previous week, Haleon had 3 more articles in the media than Smith & Nephew. MarketBeat recorded 3 mentions for Haleon and 0 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 0.22 beat Haleon's score of -0.10 indicating that Smith & Nephew is being referred to more favorably in the media. Company Overall Sentiment Smith & Nephew Neutral Haleon Neutral Do institutionals and insiders believe in SN or HLN? 62.2% of Smith & Nephew shares are owned by institutional investors. Comparatively, 43.9% of Haleon shares are owned by institutional investors. 0.2% of Smith & Nephew shares are owned by insiders. Comparatively, 10.7% of Haleon shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk & volatility, SN or HLN? Smith & Nephew has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.19, indicating that its share price is 81% less volatile than the S&P 500. Which has better valuation and earnings, SN or HLN? Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmith & Nephew£5.64B1.51£305M£0.273,614.81Haleon£11.26B3.05£1.09B£0.123,169.17 Does the MarketBeat Community favor SN or HLN? Smith & Nephew received 548 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 61.97% of users gave Smith & Nephew an outperform vote while only 29.73% of users gave Haleon an outperform vote. CompanyUnderperformOutperformSmith & NephewOutperform Votes55961.97% Underperform Votes34338.03% HaleonOutperform Votes1129.73% Underperform Votes2670.27% Is SN or HLN a better dividend stock? Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 3.0%. Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.6%. Smith & Nephew pays out 10,740.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Do analysts rate SN or HLN? Smith & Nephew currently has a consensus price target of GBX 3,956.20, suggesting a potential upside of 305.35%. Haleon has a consensus price target of GBX 415, suggesting a potential upside of 9.12%. Given Smith & Nephew's higher probable upside, equities research analysts clearly believe Smith & Nephew is more favorable than Haleon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Haleon 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SN or HLN more profitable? Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.82% beat Smith & Nephew's return on equity.Company Net Margins Return on Equity Return on Assets Smith & Nephew5.41% 5.84% 4.51% Haleon 9.66%6.82%4.45% SummarySmith & Nephew beats Haleon on 11 of the 20 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Smith & Nephew News Delivered to You Automatically Sign up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SN vs. The Competition Export to ExcelMetricSmith & NephewMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£8.51B£2.02B£5.38B£1.56BDividend Yield2.59%2.49%5.14%11.88%P/E Ratio3,614.81211.14105.971,594.20Price / Sales1.51204.311,246.69241,933.95Price / Cash18.6816.0540.3432.32Price / Book1.643.397.082.87Net Income£305M£70.94M£119.65M£170.42M7 Day Performance1.56%-1.85%2.15%-0.01%1 Month Performance-13.32%-2.16%-3.13%-0.39%1 Year Performance-4.50%27.55%33.79%105.98% Smith & Nephew Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNSmith & Nephew3.6777 of 5 starsGBX 986.80+1.1%GBX 3,956.20+300.9%-4.5%£8.60B£5.64B3,654.8118,452High Trading VolumeHLNHaleon0.8121 of 5 starsGBX 372.40+1.0%GBX 415+11.4%+15.8%£33.66B£11.26B3,071.1825,408Insider TradeNews CoverageSGEThe Sage Group2.0503 of 5 starsGBX 1,264.43-0.4%GBX 1,173-7.2%+13.8%£12.60B£2.25B4,863.1911,326Dividend IncreaseAnalyst ForecastInsider TradeNews CoverageHigh Trading VolumeWHRWarehouse REIT2.5525 of 5 starsGBX 84.70+1.2%GBX 108+27.5%+3.4%£359.86M£51.03M1,058.7561,000Dividend AnnouncementAnalyst ForecastNews CoveragePositive NewsHigh Trading VolumeANPAnparioN/AGBX 337.50-0.7%GBX 370+9.6%+29.8%£57.07M£32.72M1,878.22109Positive NewsCLXCalnex Solutions2.8056 of 5 starsGBX 60.88-0.2%GBX 115+88.9%-9.6%£53.31M£16.27M1,756.339,000Dividend CutGap UpTPXTPXimpactN/AN/AN/A-3.7%£31.96M£84.27M-142.7112,000Gap DownPNPLPineapple PowerN/AN/AN/A+0.0%£2.28MN/A-274.002High Trading VolumeLEGLegendary InvestmentsN/AGBX 0.09-5.6%N/A+0.0%£0.00N/A0.0019,900Gap DownULVRUnilever0.4185 of 5 starsGBX 4,542+0.1%GBX 4,665+2.7%+22.8%£112.64B£60.29B2,063.18148,000MXCTMaxCyteN/AGBX 266+1.5%N/A-20.3%£279.54M£45.44M-1,023.0880News Coverage Related Companies and Tools Related Companies Haleon Competitors The Sage Group Competitors Warehouse REIT Competitors Anpario Competitors Calnex Solutions Competitors TPXimpact Competitors Pineapple Power Competitors Legendary Investments Competitors Unilever Competitors MaxCyte Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SN) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smith & Nephew plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Smith & Nephew With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SN Stock Alerts